Fragment Linker Prediction Using Deep Encoder-Decoder Network for PROTAC Drug Design
Authors:
Preprint
Abstract
Drug discovery and development pipeline is a prolonged and complex process and remains challenging for both computational methods and medicinal chemists. Deep learning has shed light on various fields and achieved tremendous success in designing novel molecules in the pharmaceutical industry. We utilize state-of-the-art techniques to propose a deep neural network for rapid designing and generating meaningful drug-like Proteolysis-Targeting Chimeras (PROTACs) analogs. Our method, AIMLinker, takes the structural information from the corresponding fragments and generates linkers to incorporate them. In this model, we integrate filters for excluding non-druggable structures guided by protein-protein complexes while retaining molecules with potent chemical properties. The novel PROTACs subsequently pass through molecular docking, taking root-mean-square deviation (RMSD), the change of Gibbs free energy (Δ G binding ), and relative Gibbs free energy (ΔΔ G binding ) as the measurement criteria for testing the robustness and feasibility of the model. The generated novel PROTACs molecules possess similar structural information with superior binding affinity to the binding pockets in comparison to existing CRBN-dBET6-BRD4 ternary complexes. We demonstrate the effectiveness of AIMLinker having the power to design compounds for PROTACs molecules with better chemical properties.Keywords
All Related Versions
- Published version: Journal of Chemical Information and Modeling, 63 (10), 2918.
This publication has 39 references indexed in Scilit:
- The 'rule of three' for fragment-based drug discovery: where are we now?Nature Reviews Drug Discovery, 2013
- Biomacromolecular quantitative structure–activity relationship (BioQSAR): a proof-of-concept study on the modeling, prediction and interpretation of protein–protein binding affinityJournal of Computer-Aided Molecular Design, 2013
- Impact of linker length on the activity of PROTACsMolecular BioSystems, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- A ‘Rule of Three’ for fragment-based lead discovery?Drug Discovery Today, 2003
- The Protein Data BankNucleic Acids Research, 2000
- Receptor Surface Models. 1. Definition and ConstructionJournal of Medicinal Chemistry, 1995
- Structure-based drug design: progress, results and challengesStructure, 1994
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983